DEA Adds Obscure Cathinone to Schedule I Controlled List
Published Date: 11/17/2025
Rule
Summary
Starting December 17, 2025, 4-chloromethcathinone (4-CMC) is officially a Schedule I drug, meaning it’s now tightly controlled like other dangerous substances. This change affects anyone who makes, sells, studies, or even just possesses 4-CMC, bringing serious legal rules and penalties. The move helps the U.S. follow international drug laws and keeps communities safer without adding new costs.
Analyzed Economic Effects
5 provisions identified: 0 benefits, 4 costs, 1 mixed.
4‑CMC officially placed in Schedule I
Starting December 17, 2025, 4‑chloromethcathinone (4‑CMC) is permanently listed as a Schedule I controlled substance. This means handling or possessing any amount without proper authorization is unlawful and subject to the civil, administrative, and criminal sanctions that apply to Schedule I drugs.
DEA registration required to handle 4‑CMC
Anyone who manufactures, distributes, reverse distributes, imports, exports, engages in research, conducts instructional activities or chemical analysis with, or possesses 4‑CMC must register with DEA under 21 U.S.C. 822, 823, 957, and 958 and 21 CFR parts 1301 and 1312. Persons who currently handle 4‑CMC but are not registered must apply for registration and may not continue handling 4‑CMC unless DEA approves the registration.
Surrender or transfer stocks before the effective date
If you are unwilling or unable to obtain a Schedule I registration, you must surrender or transfer all quantities of 4‑CMC to a DEA‑registered person before the effective date (December 17, 2025). Any remaining 4‑CMC must be disposed of in accordance with 21 CFR part 1317 and all applicable laws.
Research allowed but requires Schedule I authorization
Placing 4‑CMC in Schedule I does not bar academic or scientific research, but researchers must obtain Schedule I researcher registration to handle the substance. DEA directs prospective researchers to apply through the Schedule I researcher registration program to obtain permission to study 4‑CMC.
Specific compliance duties: inventories, security, records
DEA registrants handling 4‑CMC must follow Schedule I requirements including initial inventory on the date they first handle controlled substances, inventories every two years thereafter, security and employee‑screening rules (21 CFR 1301.71‑1301.76 and 1301.90‑1301.93), labeling/packaging rules, quotas for manufacture, order form rules, and recordkeeping and reporting requirements under 21 CFR parts 1301, 1302, 1303, 1304, 1312, and 1317.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-11572 — Ashley Vermillion, N.P.; Decision and Order
Ashley Vermillion, a nurse practitioner from Maine, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her registration. This means she can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-11416 — Importer of Controlled Substances Application: CalCog Inc.
CalCog Inc. wants to become an official importer of some powerful controlled substances like LSD and 5-MeO-DMT. People and companies involved with these drugs have until July 8, 2026, to share their thoughts or ask for a hearing. This move could shake up the import scene, but no costs or changes happen until the DEA decides.
2026-10380 — Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
The DEA wants to put diphenidine, a drug, into Schedule I, which means it will be treated like the most tightly controlled substances. This change affects anyone who makes, sells, studies, or owns diphenidine, adding strict rules and penalties. You’ve got until June 25, 2026, to share your thoughts before the new rules might kick in.
2026-10253 — Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.
Previous / Next Documents
Previous: 2025-20000 — Renaming of Restricted Areas R-6302A, R-6302B, R-6302C, R-6302D, and R-6302E; Fort Cavazos, TX
The FAA is updating the names of restricted airspace areas R-6302A through R-6302E to reflect the Army’s renaming of Fort Hood, TX, to Fort Cavazos, TX. This change won’t affect airspace boundaries or how pilots use the space. The new names take effect on January 22, 2026, with no costs or new rules for anyone flying nearby.
Next: 2025-20007 — Technical Amendment to List of User Fee Airports: Addition of Five Airports, Removal of One Airport
Starting November 17, 2025, five airports in Colorado, California, Florida, and Oregon are joining the list where international flights pay user fees, while one airport in California is being removed. This change affects airlines and travelers by updating where customs fees apply, helping keep things smooth and fair. No extra costs or delays are expected—just a fresh, official airport lineup!